logo
NYSE:STVN logo

Stevanato Group Community

NYSE:STVN Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

Community Investing Ideas

STVN logo
Stevanato Group
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts

Focus On Biologics And Self-Administered Drugs Will Strengthen Future Market Position

Key Takeaways Focus on high-margin products and diverse solutions is set to drive revenue growth and enhance profitability. Strategic investments and operational optimizations aim to boost capacity, productivity, and margins across product segments.
View narrative
US$26.87
FV
15.7% undervalued intrinsic discount
9.21%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
7 days ago author updated this narrative